tetanus toxoid, TT
Immunogenicity, Safety, and Tolerability of a Hexavalent Vaccine in Infants
... (diphtheria toxoid [DT], tetanus toxoid [TT], pertussis toxoid [PT], FHA, pertussis pertactin [PRN], pertussis fi mbriae types 2 and 3 [FIM-2,3; considered as 2 antigens], inactivated ...
12
Crossreactivity and inheritance of idiotypes restricted to human anti tetanus toxoid antibodies
... of tetanus toxoid (TT) antigen was assessed by examining the capacity of two anti-idiotypic (ID) antisera raised against IgG (Fab')2 anti-TT (idiotype) from two subjects to bind radiolabeled ...
8
Solution conformation and flexibility of capsular polysaccharides from Neisseria meningitidis and glycoconjugates with the tetanus toxoid protein
... This present study investigates a recently FDA approved conjugate vaccine against serogroups A, C, W-135 and Y namely, Nimenrix ® produced by Pfizer Ltd., UK. The focus of this study has been sedimentation velocity in ...
11
Maternal Health-Care in India: The Case of Tetanus Toxoid Vaccination
... prenatal-care, Tetanus Toxoid (TT) vaccination is one of the important components of maternal health in developing ...neonatal tetanus is a leading cause of infant mortality in many developing ...
14
Elicitation of the prausnitz kustner reaction by antiidiotypic antibodies
... anti-tetanus toxoid (TT) antibodies ("idiotype") elicited a Prausnitz-Kustner reaction in normal skin sites sensitized 48 h earlier with the serum of the idiotype donor that contained IgE ...
8
Fabrication of nanoadjuvant with poly-e-caprolactone (PCL) for developing a single-shot vaccine providing prolonged immunity
... Purpose: The aim of the study was to load a model antigen, tetanus toxoid (TT), in poly-ε- caprolactone nanoparticles (PCL NPs) of two size ranges, ie, mean 61.2 nm (small) and 467.6 nm (large), and ...
14
Impaired response of lymphocytes from non insulin dependent diabetics to staphage lysate and tetanus antigen
... At the same time, we investigated the response of PBL from diabetic subjects to tetanus toxoid TT, a bacterial antigen which has been used in many studies of T-cell function, and to the [r] ...
6
Economic Status and Maternal Health: Analysis of the 2013-14 Zambia Demographic and Health Survey
... Despite all the initiatives being put in place by the Government and its cooperating partners, maternal deaths still remain rampant in Zambia. The country continues to face high levels of maternal mortality with an ...
18
Neonatal care practice and factors affecting in Southwest Ethiopia: a mixed methods study
... includes tetanus toxoid (TT) immunization, birth preparedness and complication readiness (BPCR), antenatal care (ANC) visit and adequate information on neonatal care during pregnancy; skilled care ...
10
Meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine: a new conjugate vaccine against invasive meningococcal disease
... The immunogenicity of MenACWY-TT was first evaluated in 2009 in a Phase II study comparing five formulations of experimental MenACWY-TT (differing in both polysaccha- ride content and in conjugation methods ...
15
Safety and Immunogenicity of Coadministering a Combined Meningococcal Serogroup C and Haemophilus influenzae Type b Conjugate Vaccine with 7-Valent Pneumococcal Conjugate Vaccine and Measles, Mumps, and Rubella Vaccine at 12 Months of Age
... diphtheria toxoid, and tetanus toxoid IgG levels postbooster has previously been re- ported for Hib, diphtheria toxoid, tetanus toxoid, and pertussis toxoid but had not ...
6
Human auto antiidiotypes regulating T cell mediated reactivity to tetanus toxoid
... hypersensitivity (DTH) to TT. This appeared approximately 35 d after a series of five booster immunizations. Concurrently, in vitro T cell blastogenic responses were preserved. Serum obtained when the skin tests ...
8
Haemophilus influenzae Type b Immunization in Infants in the United Kingdom: Effects of Diphtheria/Tetanus/Acellular Pertussis/Hib Combination Vaccine, Significant Prematurity, and a Fourth Dose
... anti–tetanus toxoid (anti-TT) antibody (class immunoglobulin G) were measured by commercially available enzyme immunoassay (EIA; the Binding Site, Birmingham, United Kingdom) by 1 inves- tigator ...
10
An Evaluation of the Safety and Immunogenicity of a Five-Component Acellular Pertussis, Diphtheria, and Tetanus Toxoid Vaccine (DTaP) When Combined With a Haemophilus influenzaeType b-Tetanus Toxoid Conjugate Vaccine (PRP-T) in Taiwanese Infants
... diphtheria, tetanus, and poliovirus types 1, 2, and ...postvaccination tetanus re- sponses ...a tetanus antitoxin level $ ...lower tetanus re- sponse with the combined vaccines is consistent ...
8
Seroprevalence of an antibody against diphtheria, tetanus, and pertussis among the elderly in Khon Kaen, Thailand
... Diphtheria, tetanus, and pertussis are three serious infectious diseases with an often fatal ...4]. Tetanus is a rare disease, but has a high mortality rate. Tetanus occurs by the penetration of ...
8
Isolation of circulating immune complexes using Raji cells Separation of antigens from immune complexes and production of antiserum
... Sera were obtained from rabbits tolerant to human IgG and that had been injected with either whole Raji cells carrying tetanus toxoid-human antitetanus toxoid-C complexes A, with citrate[r] ...
13
Acellular Pertussis Vaccine Booster Combined With Diphtheria and Tetanus Toxoids for Adolescents
... with tetanus toxoid and reduced diphtheria toxoid (Tdap; Boostrix, GlaxoSmithKline Bio- logicals, Rixensart, Belgium) was licensed in the United States for use in ...with tetanus toxoid ...
12
Pertussis re emergence in the post vaccination era
... pertussis toxoid (PTd), polyphosphazene (PCEP), CpG ODN 10101 and syn- thetic cationic innate defence regulator peptide 1002 (IDR) against Bordetella pertussis in ...
12
Additional Recommendations for Use of Tetanus Toxoid, Reduced-Content Diphtheria Toxoid, and Acellular Pertussis Vaccine (Tdap)
... tetanus toxoid, reduced-diphtheria toxoid, and reduced-content acellu- lar pertussis vaccine (Tdap) instead of tetanus and diphtheria toxoid vaccine (Td) for adolescents aged 11 through ...
6
Effectiveness and Cost of Immunization Recall at School-Based Health Centers
... for tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, 57% (142/248) for quadrivalent meningococcal conjugate vaccine, and 59% (149/253) for the fi rst human papillomavirus ...
9